Company intelligence / Profile preview
Andes Biotechnologies
Santiago, Chileandesbio.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Other
01
Overview
Andes Biotechnologies has developed a proprietary antisense oligonucleotide technology that targets novel long non-coding mitochondrial RNAs selectively expressed in tumor cells. Their lead candidate, Andes‑1537, has completed Phase Ia and entered Phase Ib clinical trials in the US for advanced solid tumors. Early results indicate good safety and preliminary efficacy signals. The company’s approach represents a new class of nucleic acid-based therapeutics with potential broad application across multiple solid tumor types.
- Therapeutic areas
- Oncology
- Modalities
- Antisense oligonucleotideSynthetic oligonucleotideSmall molecule (phosphorothioate backbone)
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Collaborations with national/international academic centers including University of California San Francisco Cancer Center/Mount Zion Hospital for clinical trials.
Beyond the preview
Go deeper on Andes Biotechnologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Andes Biotechnologies.